Genomic Characterization of High-Grade Serous Ovarian Cancer: Dissecting Its Molecular Heterogeneity as a Road Towards Effective Therapeutic Strategies

Current Oncology Reports · Published 2016-07-01 · Journal article · DOI 10.1007/s11912-016-0526-9 · Cited by 29 (Crossref)

Authors (1)

Lorenza Mittempergher

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

18

Issue

7

Year

2016

Citation

Mittempergher, L. (2016). Genomic Characterization of High-Grade Serous Ovarian Cancer: Dissecting Its Molecular Heterogeneity as a Road Towards Effective Therapeutic Strategies. Current Oncology Reports. https://doi.org/10.1007/s11912-016-0526-9

Related articles

• The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies · Journal of the Egyptian National Cancer Institute · 2026 · Cites or is cited by this article
• Microbiome in Gastrointestinal Tumors: Implications in Oncogenesis and Therapeutic Response · Current Oncology Reports · 2026 · Same journal
• Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC) · Current Oncology Reports · 2026 · Same journal
• Liquid Biopsy in Uterine Leiomyosarcoma: Current Biomarkers, Emerging Technologies, and Future Perspectives · Current Oncology Reports · 2026 · Same journal
• Head and Neck Rhabdomyosarcoma in Children: An Otolaryngological Perspective on Diagnostic and Therapeutic Approaches · Current Oncology Reports · 2026 · Same journal
• Next-Generation Checkpoint Combinations: Optimizing PD-(L)1–Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings · Current Oncology Reports · 2026 · Same journal
• Robotics in Interventional Oncology: A Call to Arms? · Current Oncology Reports · 2026 · Same journal
• Neuro-Oncology of Women (NOW): Special Considerations Regarding Management of Women of Reproductive Age with Glioma · Current Oncology Reports · 2026 · Same journal
• Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies · Current Oncology Reports · 2026 · Same journal
• The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies · Current Oncology Reports · 2026 · Same journal

Metrics

Citations (Crossref)

29